Capstone Investment Advisors
UTHR icon

Capstone Investment Advisors’s United Therapeutics UTHR Stock Holding History

Capstone Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Buy
1,123
+50
+5% +$28.2K ﹤0.01% 1150
2026
Q1 		$636K Sell
1,073
-76
-7% -$37.8K ﹤0.01% 1032
2025
Q4 		$560K Buy
1,149
+464
+68% +$216K ﹤0.01% 1112
2025
Q3 		$287K Buy
+685
New +$230K ﹤0.01% 1667
2025
Q2 		– Sell
-736
Closed -$227K – 1741
2025
Q1 		$227K Buy
+736
New +$252K ﹤0.01% 1249
2024
Q4 		– Sell
-812
Closed -$291K – 2023
2024
Q3 		$291K Sell
812
-252
-24% -$85.1K ﹤0.01% 1425
2024
Q2 		$339K Sell
1,064
-3,998
-79% -$1.06M ﹤0.01% 1522
2024
Q1 		$1.16M Buy
5,062
+2,410
+91% +$544K ﹤0.01% 1060
2023
Q4 		$583K Buy
2,652
+778
+42% +$179K ﹤0.01% 1273
2023
Q3 		$423K Buy
+1,874
New +$432K ﹤0.01% 1411
2017
Q4 		– Sell
-5,799
Closed -$679K – 665
2017
Q3 		$679K Buy
+5,799
New +$741K 0.02% 270
2016
Q3 		– Sell
-8,807
Closed -$932K – 921
2016
Q2 		$932K Buy
8,807
+4,807
+120% +$536K 0.02% 367
2016
Q1 		$445K Buy
+4,000
New +$506K 0.01% 439

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capstone Investment Advisors's UTHR Position: Q2 2026 in Review

Capstone Investment Advisors increased its United Therapeutics (UTHR) stake by 4.7% in Q2 2026, buying an estimated $28.2K and bringing the position to 1,123 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Capstone Investment Advisors first reported a position in UTHR in Q1 2016 and has held it in 13 quarters since. The position peaked at $1.16M in Q1 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Capstone Investment Advisors held 1,123 shares of United Therapeutics worth $608K as of Q2 2026.
  • Capstone Investment Advisors bought 50 United Therapeutics shares in Q2 2026, an estimated $28.2K.
  • United Therapeutics made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1150 holding.
  • Capstone Investment Advisors first reported a position in United Therapeutics in Q1 2016 and has held it in 13 quarters since.
  • Capstone Investment Advisors's United Therapeutics position peaked at $1.16M in Q1 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.